Literature DB >> 21803151

ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.

Zahra Tanfin1, Martin Serrano-Sanchez, Denis Leiber.   

Abstract

Sphingosine 1-phosphate (S1P), a bioactive lipid generated by sphingosine kinases (SphK1/2), initiates different signalling pathways involved in physiological and pathological processes. We previously demonstrated that in rat myometrium at late (day 19) gestation, SphK1 increases the expression of COX2 via S1P generation and release. In rat uterine leiomyoma cells (ELT3), SphK1/S1P axis controls survival and proliferation. In the present study we demonstrate that PDBu activates SphK1 but not SphK2. SphK1 activation requires PKC and MAPK ERK1/2. S1P produced by PDBu is released in the medium. PDBu-induced S1P export is abolished by Ro-318220 and BIM (PKC inhibitors), by U0126 and PD98059 (MEK inhibitors), SKI-II (SphKI/2 inhibitor) and SphK1-siRNA, suggesting the involvement of PKC, ERK and SphK1 respectively. The release of S1P is insensitive to inhibitors of ATP Binding Cassette (ABC)A1 and ABCB1 transporters, but is abolished when ABCC1 transporters are inhibited by MK571 or down-regulated by ABCC1-siRNA. PDBu increases COX2 expression that is blocked by the inhibition of PKC, ERK1/2, SphK1, and when cells are treated with MK571 or transfected with ABCC1-siRNA. The induction of COX2 by the S1P release due to PDBu or by exogenous S1P involves S1P2 receptors coupled to Gi. In myometrium from rat at late gestation, the release of S1P is also strongly reduced when SphK and ABCC1 are inhibited. The data reveal that in rat leiomyoma cells and late pregnant rat myometrium, the release of S1P involves a similar signalling pathway and occurs through ABCC1.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803151     DOI: 10.1016/j.cellsig.2011.07.010

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  16 in total

1.  Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease.

Authors:  Ashley J Snider
Journal:  Int J Clin Rheumtol       Date:  2013-08-01

2.  Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant.

Authors:  Knapp Paweł; Adrian Chabowski; Jan Górski
Journal:  Lipids       Date:  2012-12-14       Impact factor: 1.880

3.  The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.

Authors:  Alejandra Mendoza; Béatrice Bréart; Willy D Ramos-Perez; Lauren A Pitt; Michael Gobert; Manjula Sunkara; Juan J Lafaille; Andrew J Morris; Susan R Schwab
Journal:  Cell Rep       Date:  2012-10-25       Impact factor: 9.423

Review 4.  Export of sphingosine-1-phosphate and cancer progression.

Authors:  Kazuaki Takabe; Sarah Spiegel
Journal:  J Lipid Res       Date:  2014-01-28       Impact factor: 5.922

Review 5.  Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter.

Authors:  Susan P C Cole
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

Review 6.  ATP-binding cassette transporters in reproduction: a new frontier.

Authors:  E Bloise; T M Ortiga-Carvalho; F M Reis; S J Lye; W Gibb; S G Matthews
Journal:  Hum Reprod Update       Date:  2015-11-05       Impact factor: 15.610

7.  Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Authors:  Ronald E Cannon; John C Peart; Brian T Hawkins; Christopher R Campos; David S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

8.  Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells.

Authors:  Yu Hisano; Naoki Kobayashi; Akihito Yamaguchi; Tsuyoshi Nishi
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

9.  Sphingosine kinase: a novel putative target for the prevention of infection-triggered preterm birth.

Authors:  Vibhuti Vyas; Charles R Ashby; Sandra E Reznik
Journal:  Obstet Gynecol Int       Date:  2013-05-26

10.  Sphingolipids: a potential molecular approach to treat allergic inflammation.

Authors:  Wai Y Sun; Claudine S Bonder
Journal:  J Allergy (Cairo)       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.